Cost-effectiveness of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema treatment analysis from the diabetic retinopathy clinical research network comparative effectiveness trial

Eric L. Ross, David W. Hutton, Joshua D. Stein, Neil M. Bressler, Lee M. Jampol, Adam R. Glassman

Research output: Contribution to journal › Article › peer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema treatment analysis from the diabetic retinopathy clinical research network comparative effectiveness trial'. Together they form a unique fingerprint.

Medicine & Life Sciences